SOLIGENIX, INC. Interest Income (Expense), Net
SOLIGENIX, INC. (SNGX) reported Interest Income (Expense), Net of -$201.47 thousand for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-13.
Discontinued › Income Statement › Other Income
us-gaap:InterestIncomeExpenseNet · last filed 2022-05-13
- SOLIGENIX, INC. interest income (expense), net for the quarter ending 2022-03-31 was -$201.47K.
- SOLIGENIX, INC. interest income (expense), net for the quarter ending 2021-12-31 was -$217.52K.
- SOLIGENIX, INC. interest income (expense), net for the quarter ending 2021-09-30 was -$216.80K, a 44709.05% decline year-over-year.
- SOLIGENIX, INC. interest income (expense), net for the quarter ending 2021-06-30 was -$214.75K, a 10747.00% decline year-over-year.
- SOLIGENIX, INC. interest income (expense), net for fiscal 2021 was -$862.58K.
- SOLIGENIX, INC. interest income (expense), net for fiscal 2020 was -$10.88K, a 107.30% decline from fiscal 2019.
- SOLIGENIX, INC. interest income (expense), net for fiscal 2019 was $148.97K.
- SOLIGENIX, INC. interest income (expense), net for fiscal 2016 was $2.22K.
| Period end | Interest Income (Expense), Net 3 month | Interest Income (Expense), Net 6 month | Interest Income (Expense), Net 9 month | Interest Income (Expense), Net 12 month |
|---|---|---|---|---|
| 2022-03-31 | -$201.47K 10-Q · filed 2022-05-13 | -$418.99K derived: sum of 2 quarters · filed 2022-05-13 | -$635.79K derived: sum of 3 quarters · filed 2022-05-13 | -$850.54K derived: sum of 4 quarters · filed 2022-05-13 |
| 2021-12-31 | -$217.52K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | -$434.32K derived: sum of 2 quarters · filed 2022-03-29 | -$649.07K derived: sum of 3 quarters · filed 2022-03-29 | -$862.58K 10-K · filed 2022-03-29 |
| 2021-09-30 | -$216.80K 10-Q · filed 2021-11-12 | -$431.55K derived: sum of 2 quarters · filed 2021-11-12 | -$645.05K 10-Q · filed 2021-11-12 | -$680.39K derived: sum of 4 quarters · filed 2022-05-13 |
| 2021-06-30 | -$214.75K 10-Q · filed 2021-08-13 | -$428.25K 10-Q · filed 2021-08-13 | -$463.59K derived: sum of 3 quarters · filed 2022-05-13 | -$463.10K derived: sum of 4 quarters · filed 2022-05-13 |
| 2021-03-31 | -$213.50K 10-Q · filed 2022-05-13 | -$248.84K derived: sum of 2 quarters · filed 2022-05-13 | -$248.35K derived: sum of 3 quarters · filed 2022-05-13 | -$246.33K derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | -$35.33K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | -$34.85K derived: sum of 2 quarters · filed 2022-03-29 | -$32.83K derived: sum of 3 quarters · filed 2022-03-29 | -$10.88K 10-K · filed 2022-03-29 |
| 2020-09-30 | $486.00 10-Q · filed 2021-11-12 | $2.50K derived: sum of 2 quarters · filed 2021-11-12 | $24.45K 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $2.02K 10-Q · filed 2021-08-13 | $23.96K 10-Q · filed 2021-08-13 | ||
| 2020-03-31 | $21.95K 10-Q · filed 2021-05-18 | |||
| 2019-12-31 | $148.97K 10-K · filed 2021-03-30 | |||
| 2017-06-30 | $5.23K 10-Q · filed 2017-08-11 | $9.98K 10-Q · filed 2017-08-11 | $12.94K derived: sum of 3 quarters · filed 2017-08-11 | $14.83K derived: sum of 4 quarters · filed 2017-08-11 |
| 2017-03-31 | $4.75K 10-Q · filed 2017-05-11 | $7.71K derived: sum of 2 quarters · filed 2017-05-11 | $9.60K derived: sum of 3 quarters · filed 2017-05-11 | $10.85K derived: sum of 4 quarters · filed 2017-08-11 |
| 2016-12-31 | $2.95K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-27 | $4.84K derived: sum of 2 quarters · filed 2017-03-27 | $6.10K derived: sum of 3 quarters · filed 2017-08-11 | $2.22K 10-K · filed 2017-03-27 |
| 2016-09-30 | $1.89K 10-Q · filed 2016-11-10 | $3.15K derived: sum of 2 quarters · filed 2017-08-11 | -$736.00 10-Q · filed 2016-11-10 | -$6.14K derived: sum of 4 quarters · filed 2017-08-11 |
| 2016-06-30 | $1.26K 10-Q · filed 2017-08-11 | -$2.63K 10-Q · filed 2017-08-11 | -$8.03K derived: sum of 3 quarters · filed 2017-08-11 | -$11.76K derived: sum of 4 quarters · filed 2017-08-11 |
| 2016-03-31 | -$3.88K 10-Q · filed 2017-05-11 | -$9.29K derived: sum of 2 quarters · filed 2017-05-11 | -$13.01K derived: sum of 3 quarters · filed 2017-05-11 | -$12.46K derived: sum of 4 quarters · filed 2017-05-11 |
| 2015-12-31 | -$5.40K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-27 | -$9.13K derived: sum of 2 quarters · filed 2017-03-27 | -$8.58K derived: sum of 3 quarters · filed 2017-03-27 | -$8.02K 10-K · filed 2017-03-27 |
| 2015-09-30 | -$3.73K 10-Q · filed 2016-11-10 | -$3.18K derived: sum of 2 quarters · filed 2016-11-10 | -$2.62K 10-Q · filed 2016-11-10 | -$2.35K derived: sum of 4 quarters · filed 2016-11-10 |
| 2015-06-30 | $551.00 10-Q · filed 2016-08-11 | $1.11K 10-Q · filed 2016-08-11 | $1.38K derived: sum of 3 quarters · filed 2016-08-11 | $1.81K derived: sum of 4 quarters · filed 2016-08-11 |
| 2015-03-31 | $561.00 10-Q · filed 2016-05-12 | $830.00 derived: sum of 2 quarters · filed 2016-05-12 | $1.26K derived: sum of 3 quarters · filed 2016-05-12 | $1.58K derived: sum of 4 quarters · filed 2016-05-12 |
| 2014-12-31 | $269.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-24 | $697.00 derived: sum of 2 quarters · filed 2016-03-24 | $1.02K derived: sum of 3 quarters · filed 2016-03-24 | $1.31K 10-K · filed 2016-03-24 |
| 2014-09-30 | $428.00 10-Q · filed 2015-11-12 | $750.00 derived: sum of 2 quarters · filed 2015-11-12 | $1.04K 10-Q · filed 2015-11-12 | |
| 2014-06-30 | $322.00 10-Q · filed 2015-08-12 | $613.00 10-Q · filed 2015-08-12 | ||
| 2014-03-31 | $291.00 10-Q · filed 2015-05-14 | |||
| 2013-09-30 | $652.00 10-Q · filed 2014-11-10 | $1.44K 10-Q · filed 2014-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |